Cooper Companies stock
Price history
−12.68% over the period1 year: from $71.75 (November 13, 2025) to $62.65 (November 13, 2026), −12.68%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 13, 2026 | $62.65 |
| October 30, 2026 | $59.55 |
| September 30, 2026 | $56.53 |
| August 31, 2026 | $70.09 |
| July 31, 2026 | $72.32 |
| June 30, 2026 | $71.71 |
| May 29, 2026 | $61.21 |
| April 30, 2026 | $62.90 |
| March 31, 2026 | $71.50 |
| February 27, 2026 | $83.67 |
| January 30, 2026 | $81.38 |
| December 31, 2025 | $81.96 |
| November 28, 2025 | $77.93 |
| November 13, 2025 | $71.75 |
At a glance
The company
Develops and markets contact lenses, and provides family and women's health care products including fertility solutions and contraceptive devices
Latest results
Quarter to July 31, 2026 · EPS $1.15 (estimate $1.12)
Next event
TickerLandia's take on Cooper Companies
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 34 vs a median of 45 over its last 4 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 22 vs 34 (−37%) in a group of 9.
- Strong point: Earnings stability (72/100 in its group). Weak point: Market momentum (27/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−30.26% from the 52-week high
Analysts · 17 analysts
Average target$65.80+5.03% vs. price
Buy 5 · Hold 12 · Sell 0 · Hold
TickerLandia Fingerprint: Cooper Companies
Compared with similar companies: low price, weak momentum, and high earnings stability.
Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 883 North American stocks.
Pricelow22
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 13.4 13 Price/book 1.43 4 Price/sales 2.81 40 P/E (trailing 12 months) 21.5 12 EV/EBITDA 15.6 43 Profitabilityaverage49
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 12.9% 43 Gross margin 65.9% 78 Net margin 13.5% 72 ROE 6.8% 34 ROA 2.7% 19 Earnings stabilityhigh72
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.4% 81 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 63 Growthaverage57
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +7.35% 60 Revenue growth (year over year) +0.60% 19 Earnings growth (year over year) +357.10% 92 Financial strengthaverage40
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 6.87 48 Debt/equitycounts in reverse: lower means more financial strength 0.34 56 Current ratio 1.22 28 Net debt/EBITDAcounts in reverse: lower means more financial strength 2.47 29 Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumweak27
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −15.64% 15 Relative strength (6 months) +3.71% 52 1-year return −12.68% 17 Distance from 200-day average −7.82% 23 Riskaverage60
How much the price swings.
Metric Value Position in group Volatility (60 days) 45.8% 71 Beta (1 year) 0.48 40 Maximum drawdown (12 months) 36.8% 68
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Cooper Companies is cheaper than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Cooper Companies's P/E today is 33.5, below the median of its last 4 fiscal years (45.0; between 35.2 and 53.4 from 2022 to 2025). Cooper Companies's P/E (trailing 12 months): 21.5, −37% against the median of a group of 9 similar companies (34.2).
Compared with 9 similar companies
| Metric | Cooper Companies | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 21.5 | Low | |
| Forward P/E | 13.4 | Low | |
| Operating margin | 12.9% | Middle | |
| ROE | 6.8% | Middle | |
| Debt/equity | 0.34 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Cooper Companies. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$1.07B
Latest quarter · Q to Jul 2026
Net income
$432.8M
Latest quarter · Q to Jul 2026
Quarterly net margin
40.6%
Latest quarter · Q to Jul 2026
Numbers and valuation
Full valuation- Market cap
- $11.91B
- P/E
- 21.5
- EPS
- $2.91
- Volume
- 1.57M
- Daily trading
- €143.13M
How Cooper Companies is changing
All resultsRevenue grew 11.0% a year on average over the last 5 years
Operating margin rose from 15.3% to 16.7%
Free cash flow equal to 88% of net income
Returns
Cooper Companies returns with dividends
$1,000 invested in Cooper Companies 5 years ago, on November 15, 2021, would be worth $602 today with dividends reinvested: −39.80% in total, −9.66% per year. On price alone it would be $602 (−39.82%).
| Period | Cooper Companies | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +14.76% | −3.12% | $1,148 |
| 6 months | +5.35% | +1.58% | $1,053 |
| Year to date | −23.56% | +10.46% | $764 |
| 1 year | −12.68% | +12.23% | $873 |
| 3 years | −24.19% | +71.41% | $758 |
| 5 years | −39.80% | +61.48% | $602 |
| 10 years | +47.51% | +249.40% | $1,475 |
Over the last 6 months it has done better than 32% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Cooper Companies: technical analysis
Cooper Companies shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 45.0% below its highest close since January 2, 1990 ($113.98, September 3, 2021).
- Trend
- No clear trend
- RSI (14 sessions)
- 57
- Between 30 and 70
- vs 200-session average
- −7.82%
Support and resistance
Price areas where Cooper Companies has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$72.59+15.87%2 touches, last on April 14, 2026
- Resistance$68.69+9.64%3 touches, last on July 14, 2026
- Resistance$65.24+4.13%2 touches, last on November 5, 2026
- Last price$62.65
- Support$59.01−5.80%2 touches, last on June 2, 2026
Volatility and risk
Over the last year it has moved less than the S&P 500.
- Beta (1 year) vs S&P 500
- 0.48
- Volatility (60 sessions, annualised)
- 45.8%
- Largest fall in the last year
- −36.82%
Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Cooper Companies: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Cooper Companies has been March: +4.98% on average, positive in 27 years out of 37. The weakest has been October: −2.57% on average, positive in 20 years out of 37. November, the current month, has been positive in 20 years out of 36 (+0.51% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +2.94% | +2.53% | 24 of 36 |
| February | +0.40% | +2.69% | 22 of 37 |
| March | +4.98% | +3.56% | 27 of 37 |
| April | −0.17% | +0.03% | 19 of 37 |
| May | +2.51% | +2.08% | 20 of 37 |
| June | −0.07% | 0.00% | 18 of 37 |
| July | +2.92% | +0.15% | 19 of 37 |
| August | +2.40% | +1.34% | 19 of 37 |
| September | +2.14% | +0.96% | 19 of 37 |
| October | −2.57% | +0.95% | 20 of 37 |
| November | +0.51% | +1.37% | 20 of 36 |
| December | +2.63% | +2.93% | 20 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Cooper Companies and its competitors
CooperVision, the contact lens segment, makes spherical, toric and multifocal lenses that correct astigmatism, presbyopia and myopia. The second segment, CooperSurgical, serves women's healthcare with fertility consumables and equipment, contraceptive devices, the hormone-free Paragard intrauterine device, and storage of umbilical cord material. Its products reach distributors, group purchasing bodies, eye care clinicians, hospitals, clinics and authorized resellers across several regions.
- Headquarters
- San Ramon, United States
- Employees
- 15,000
- Founded
- 1980
- Chief executive
- Albert White
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Cooper CompaniesCOO | $11.91B | 12.9% | 21.5 | +5.35% |
| Align TechnologyALGN | $11.86B | 19.6% | 24.5 | +4.06% |
| Baxter InternationalBAX | $13.35B | 7.6% | — | +49.10% |
| AvantorAVTR | $10.53B | 8.0% | 31.1 | +97.46% |
| RepligenRGEN | $10.73B | 8.1% | — | +56.77% |
| SolventumSOLV | $15.14B | 5.9% | 100.1 | +19.72% |
Same industry or related industries, similar size. Compare Cooper Companies with its competitors · Full profile
